Prevention of Progression in Myopia: A Systematic Review
Aldo Vagge, Lorenzo Ferro Desideri, Paolo Nucci, Massimiliano Serafino, Giuseppe Giannaccare, and Carlo E. Traverso
Publication: Diseases Journal - MDPI

Published in 2018

Key Highlights:

  • The prevalence of myopia has increased worldwide in recent decades and now is endemic
  • over the entire industrial world. This increase is mainly caused by changes in lifestyle and behavior.
  • In particular, the amount of outdoor activities and near work would display an important role in the pathogenesis of the disease.Several strategies have been reported as effective.
  • Spectacles and contact lenses have shown only slight results in the prevention of myopia and similarly ortokerathology should not be considered as a first-line strategy, given the high risk of infectious keratitis and the relatively low compliance for the patients.
  • Thus, to date, atropine ophthalmic drops seem to be the most effective treatment for slowing the progression of myopia, although the exact mechanism of the effect of treatment is still uncertain.
  • In particular, low-dose atropine (0.01%) was proven to be an effective and safe treatment in the long term due to the lowest rebound effect with negligible side effects.

To access the report, click here:  https://www.mdpi.com/2079-9721/6/4/92

To download the full report, click here: Prevention of Progression in Myopia: A Systematic Review



WeChat QR Code